Global Phacoemulsification Devices Market: By Product Type (Devices, Accessories) By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Distribution Channel (Hospitals, Ophthalmic Clinics, Others), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global phacoemulsification devices market is projected to reach USD 374 Mn by 2027 growing at a CAGR of 4.3% during the forecast period 2021 to 2027. Phacoemulsification is a cataract surgical procedure in which the internal lens of the eye is emulsified. The procedure is carried out by performing incisions in the eye to allow the surgical instruments. Two small incisions are made in the eye where the clear front covering of the eye (Cornea) meets the sclera. A circular opening is made in the front part of lens capsule. A surgical instrument (phaco probe) is inserted into the eye. The lens is broken and is removed, the surgeon uses suction in order to remove the pieces of the lens. The popularity of the phacoemulsification technology has risen dramatically as a result of technological improvements that have increased its efficiency and safety. The success of this method is due to the development of viscoelastic agents combined with contemporary phacoemulsification processes. The incidence of both postoperative and intraoperative capsular problems has decreased as a result of improved surgical procedures for removing anterior lens capsules. Furthermore, nucleus removal is now performed in the posterior chamber rather than the anterior chamber, resulting in less injury to the corneal endothelium. During the projected period, the phacoemulsification devices market is expected to grow at a significant rate. The benefits associated with phacoemulsification devices, including as smaller incisions, quick recovery, no need for hospitalisation, fewer intraoperative and postoperative problems, and early visual rehabilitation, have contributed to the market's rise. Furthermore, the high popularity of the phacoemulsification procedure for the surgical removal of cataracts is due to no restrictions on regular activities and less caused astigmatism due to a smaller incision.

Phacoemulsification Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market


Increase in prevalence of eye diseases and growing geriatric population with refractive errors are anticipated to drive the phacoemulsification devices market. The increased awareness about advanced surgical procedures, adoption of the modern surgical treatments, support from the government and the non-profitable organizations are expected to drive the growth of phacoemulsification devices market. The improving healthcare infrastructure, adoption of new treatment methods are expected to offers for market players. However, the high cost of the device, poor reimbursement policies and stringent government regulations are expected to hamper the growth of phacoemulsification devices market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Phacoemulsification Devices Market Segmentation

Product Type
  • Devices
  • Accessories
  • Manually Operated Inhalers
  • Digitally Operated Inhalers
Distribution Channel
  • Hospitals
  • Ophthalmic Clinics
  • Others


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Johnson & Johnson Vision (U.S)
  • Zeiss (Germany)
  • NIDEK (Japan)
  • Alcon (U.S)
  • Baush + Lomb (U.S)
  • Optikon (Italy)
  • MEDA Co. LTD (China)
  • Topcon (Japan)